首页 正文

The clinical advances of proteolysis targeting chimeras in oncology

{{output}}
Proteolysis targeting chimeras (PROTACs) are a class of small molecules designed to target proteins for degradation. Their novel and unique modes of action provide PROTACs with the potential for their application in the management of both solid and hematologic... ...